Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Viruses ; 15(1)2022 12 30.
Artículo en Inglés | MEDLINE | ID: mdl-36680152

RESUMEN

The present study aims to provide the sequential immunological, clinical and virological events occurring in a CMV-infected pregnant woman experiencing intrauterine CMV transmission. In brief, a case of primary CMV infection occurred in a 36-year-old pregnant woman. The patient exhibited early-sustained viremia and viruria, detectable presence of CMV in saliva concomitant with a strong CMV-specific cell-mediated response (427 EliSpots). CMV was detected in the amniotic fluid at 15 weeks of pregnancy (>1 × 106 CMV copies/mL). The pregnancy was deliberately interrupted at 16 weeks of gestation. Fetal histological and pathological examinations revealed placentitis and fetal brain alterations as microcephaly and cortical dysplasia. Interestingly, this clinical report shows: (1) there was a rapid and sustained CMV-specific cell mediated immune response (Th1) in association with low IgG avidity (Th2) correlated with fetal CMV transmission. (2) The levels of CMV-specific cell-mediated immune response persisted at high levels up to 200 weeks after infection despite clinical and viral clearance. (3) The histological and pathological evidence suggests that a potent pro-inflammatory condition at the placental level may lead to cCMV.


Asunto(s)
Enfermedades Transmisibles , Infecciones por Citomegalovirus , Enfermedades Fetales , Complicaciones Infecciosas del Embarazo , Embarazo , Femenino , Humanos , Adulto , Citomegalovirus , Estudios de Seguimiento , Transmisión Vertical de Enfermedad Infecciosa , Placenta , Infecciones por Citomegalovirus/complicaciones , Infecciones por Citomegalovirus/diagnóstico , Líquido Amniótico
2.
Int J Gynecol Pathol ; 39(4): 305-312, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31688243

RESUMEN

Carcinosarcomas are rare, highly aggressive neoplasms composed of a combination of carcinomatous and sarcomatous elements. These tumors represent a paradigmatic field for the study of intratumor heterogeneity. A series of 8 tubo-ovarian carcinosarcomas was characterized for the following: (i) immunohistochemical expression of MNF116, epithelial membrane antigen, vimentin, S100, chromogranin, synaptophysin, desmin, myogenin (MYF4), and p53; (ii) mutational profiling of KRAS, BRAF, PIK3CA, NRAS, TP53, and DICER1 genes. Heterologous differentiation was present in 6 of 8 tumors. Cytokeratin MNF116 and epithelial membrane antigen were positive in all the carcinomatous components and in 87.5% and 50.0% of the sarcomatous components, respectively. The sarcomatous components showed positive staining for vimentin in all cases. Two cases demonstrated positivity for neuroendocrine markers in their carcinomatous components. All rhabdomyosarcomas were positive for desmin and MYF-4. Chondrosarcomas were positive for S100. All but one tumor showed similar p53 immunoreactivity in both the carcinomatous and sarcomatous components, and one case showed cytoplasmic p53 expression. Three of 8 cases (37.5%) showed TP53 mutations, and, in 2 cases, the TP53 mutation was shared by both epithelial and mesenchymal components. DICER1 mutation was found in all components of one case. Mutations in KRAS, NRAS, BRAF, and PIK3CA genes were not found in the study cohort. Our results highlight the heterogeneity of ovarian carcinosarcomas at the phenotypic level. A common mutational signature was observed in both components in 3 of 4 informative tumors. More studies are required to dissect different levels of ovarian carcinosarcomas' heterogeneity in order to define the best therapeutic approaches to these aggressive neoplasms.


Asunto(s)
Biomarcadores de Tumor/genética , Carcinosarcoma/genética , ARN Helicasas DEAD-box/genética , Neoplasias de las Trompas Uterinas/genética , Neoplasias Ováricas/genética , Ribonucleasa III/genética , Proteína p53 Supresora de Tumor/genética , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/metabolismo , Carcinosarcoma/metabolismo , Carcinosarcoma/patología , Estudios de Cohortes , ARN Helicasas DEAD-box/metabolismo , Neoplasias de las Trompas Uterinas/metabolismo , Neoplasias de las Trompas Uterinas/patología , Femenino , Heterogeneidad Genética , Humanos , Inmunohistoquímica , Inmunofenotipificación , Persona de Mediana Edad , Mutación , Neoplasias Ováricas/metabolismo , Neoplasias Ováricas/patología , Fenotipo , Ribonucleasa III/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
3.
Sensors (Basel) ; 18(7)2018 Jul 09.
Artículo en Inglés | MEDLINE | ID: mdl-29987221

RESUMEN

The forthcoming fifth generation (5G) networks are claimed to deliver the large amount of traffic generated by the huge number of heterogeneous devices that constitute the Internet of Things (IoT). This unprecedented volume of both human- and machine-generated traffic to be managed imposes 5G network operators to move the focus from throughput-optimized to energy-efficiency-optimized resource allocation solutions. Device-to-device (D2D) communications are recognized as an effective offloading technique that the 5G network can exploit to boost the capacity and energy efficiency of future 5G networks. In this paper, we design a technique to efficiently deliver multicast traffic in a 5G New Radio (NR) network by exploiting the benefits of D2D communication and single-frequency operation in order to improve the overall network energy efficiency. In the designed solution, the subset of devices in better channel conditions are served through a conventional multicast transmission, while cell-edge devices receive the multicast service from relay nodes that simultaneously transmit in D2D mode the same content. The dimension of the multicast serving area and the set of D2D connections to establish are chosen in order to maximize the overall network energy efficiency. Performed simulation results show the effectiveness of the proposed solution under varying frame configurations and number of multicast devices.

4.
Fertil Steril ; 110(1): 103-112.e1, 2018 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-29908776

RESUMEN

OBJECTIVE: To evaluate the impact of antibiotic therapy for chronic endometritis (CE) on IVF outcome. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Infertile women with history of recurrent implantation failure, defined as two or more failed ETs, undergoing one or more IVF cycle(s). INTERVENTION(S): The review was registered in PROSPERO (CRD42017062494) before the start of the literature search. Observational studies were identified by searching electronic databases. The following comparators were included: women with CE receiving antibiotics vs. untreated controls; women with cured CE vs. women with persistent CE; and women with cured CE vs. women with normal endometrial histology (negative for CE). The summary measures were reported as odds ratio (OR) with 95% confidence interval (CI). MAIN OUTCOME MEASURE(S): Clinical pregnancy rate (CPR), ongoing pregnancy rate/live birth rate (OPR/LBR), implantation rate (IR), miscarriage rate. RESULT(S): A total of 796 patients (from five studies) were included. Women receiving antibiotic therapy (without the histologic confirmation of CE cure) did not show any advantage in comparison with untreated controls (OPR/LBR, CPR, and IR). Patients with cured CE showed higher OPR/LBR (OR 6.81), CPR (OR 4.02), and IR (OR 3.24) in comparison with patients with persistent CE. In vitro fertilization outcome was comparable between women with cured CE and those without CE (OPR/LBR, CPR, and IR). Miscarriage rate was not significantly different between groups. CONCLUSION(S): Chronic endometritis therapy may improve IVF outcome in patients suffering from recurrent implantation failure. A control biopsy should always confirm CE resolution before proceeding with IVF.


Asunto(s)
Aborto Habitual/epidemiología , Aborto Habitual/terapia , Endometritis/epidemiología , Endometritis/terapia , Fertilización In Vitro , Infertilidad Femenina , Resultado del Embarazo , Aborto Habitual/etiología , Enfermedad Crónica , Implantación del Embrión/fisiología , Endometritis/complicaciones , Femenino , Fertilización In Vitro/métodos , Fertilización In Vitro/estadística & datos numéricos , Humanos , Infertilidad Femenina/epidemiología , Infertilidad Femenina/etiología , Infertilidad Femenina/terapia , Embarazo , Resultado del Embarazo/epidemiología , Índice de Embarazo , Recurrencia , Resultado del Tratamiento
5.
World J Surg Oncol ; 12: 105, 2014 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-24755359

RESUMEN

Primary extra-gastrointestinal stromal tumor (EGISTs) arising in the pancreas is extremely rare: only 20 cases have previously been reported in the English literature from 2000 to 2013. We reported a case of EGIST of the pancreas in a 69-year-old woman who presented with abdominal pain and with a solid, heterogeneously enhancing neoplasm in the uncinate process of the pancreas, revealed preoperatively by an abdominal computed tomography scan. A diagnosis of neuroendocrine tumor was suggested. Positron emission tomography with 68Ga-DOTATOC did not show pathological accumulation of the tracer in the pancreas. The patient underwent enucleation, under ultrasonic guidance, of the pancreatic tumor that emerged to the surface of the pancreas. Histopathology and immunohistochemical examination confirmed the final diagnosis of EGIST of the pancreas (CD117+), with one mitosis per 50 high-power fields. Although rarely, GIST can involve the pancreas as a primary site, and this tumor should be considered in the differential diagnosis of pancreatic neoplasms.


Asunto(s)
Tumores del Estroma Gastrointestinal/patología , Neoplasias Pancreáticas/patología , Anciano , Femenino , Tumores del Estroma Gastrointestinal/cirugía , Humanos , Neoplasias Pancreáticas/cirugía , Pronóstico , Tomografía Computarizada por Rayos X
6.
Anticancer Res ; 30(6): 2311-7, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20651385

RESUMEN

BACKGROUND: Prognostic factors such as surgery and pathology in vulvar squamous cell carcinoma are studied. PATIENTS AND METHODS: 47 patients with vulva squamous cell carcinoma treated at the Gynecology Department of the University of Padua, have been retrospectively studied. RESULTS: At the univariate relapse-free survival analysis, a significant association was found for histological grade, stage of disease and type of surgery. All patients presented vulvar squamous cell carcinoma: G(1) in 25 (53%), G(2) in 14 (30%), and G(3) in 8 (17%) patients. The distribution of stages was as following: stage 1 in 6 (13%), stage 2 in 20 (43%), stage 3 in 11 (23%), and stage 4 in 10 patients (21%). Radiotherapy was performed in 13 patients. Among the 47 patients evaluable: 26 (55.3%) developed local recurrence, 12 of these patients developed a second local relapse, 3 of these also had distant metastases (lung in 1 patient, lomboaortic and mediastinic lymph nodes in the other 2 patients). Stromal invasions were 9 mm in 30 patients with 27 relapses (univariated analysis p=0 0066). Five episodes (10,6%) of thrombosis were observed. CONCLUSION: After multivariate analysis, surgery, stage and stromal invasion over 9 mm (hazard ratio=3.1; 95% confidence interval: 1.3-7.7) proved to be the most dominant predictor for relapse-free survival. Histological grades 1 and 2 were predictive of better disease-free survival (p=0.0012).


Asunto(s)
Neoplasias de la Vulva/mortalidad , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Trombosis/etiología , Neoplasias de la Vulva/patología , Neoplasias de la Vulva/terapia
8.
Histol Histopathol ; 24(2): 175-85, 2009 02.
Artículo en Inglés | MEDLINE | ID: mdl-19085834

RESUMEN

The purposes of this study were to evaluate the prognostic significance of Glut-1 expression in patients with pancreatic ductal adenocarcinoma, and to analyse its expression in pancreatic intraepithelial neoplasias (PanIN) and non invasive intraductal papillary mucinous neoplasms (IPMN). Glut-1 expression was studied by immunohistochemistry in 60 pancreatic ductal adenocarcinomas and scored on a 4-point scale (1: <25%; 2: 25-50%; 3: 50-75%; 4: >75%). Relationships between Glut-1 score, histological grade and MIB-1 score were evaluated by the Spearman rank correlation test. Significant correlations were found between Glut-1 expression and histological grade (P<0.001) and MIB-1 score (P<0.01). Significant prognostic factors by univariate analysis were stage (P<0.0001), histological grade (P<0.001) and Glut-1 expression (P<0.005). Independent prognostic factors after multivariate analysis were stage (P<0.001) and Glut-1 expression (P<0.05), stratified as <50% and >50%. The correlation of Glut-1 score with histological grade and MIB-1 score indicated a higher glucose uptake in poorly differentiated and highly proliferative pancreatic cancer cells. Glut-1 immunohistochemical expression provides a useful prognostic factor in pancreatic ductal adenocarcinoma. Glut-1 expression was not found in PanINs 1 but in 27.8% and 43.8% of PanINs 2 and 3, and was not found in IPMNs with low- and moderate-grade dysplasia but in 60% of IPMNs with high-grade dysplasia, indicating Glut-1 involvement in a relatively early phase of pancreatic carcinogenesis.


Asunto(s)
Adenocarcinoma/metabolismo , Carcinoma Ductal Pancreático/metabolismo , Regulación Neoplásica de la Expresión Génica , Transportador de Glucosa de Tipo 1/biosíntesis , Neoplasias Pancreáticas/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Proliferación Celular , Femenino , Transportador de Glucosa de Tipo 1/fisiología , Humanos , Inmunohistoquímica/métodos , Masculino , Persona de Mediana Edad , Pronóstico
10.
J Clin Pathol ; 60(3): 278-82, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16644876

RESUMEN

AIMS: To report three cases of serous cystadenoma and endocrine tumour in the same pancreas, to review the literature and to evaluate the clinicopathological features of the tumours. CASES: Three women (71, 57 and 31 years old) were admitted to hospital, two for diseases unrelated to the pancreas and the third for increasing obstructive jaundice in von Hippel-Lindau disease. Preoperative examination showed two distinct lesions in the first patient and only cystic lesions in the other two. RESULTS: Histological examination of the pancreas showed one serous oligocystic adenoma associated with a benign, well-differentiated endocrine tumour, one serous oligocystic adenoma associated with an endocrine microadenoma, and a von Hippel-Lindau-related cystic neoplasm with a well-differentiated endocrine carcinoma. CONCLUSIONS: Serous cystadenoma associated with endocrine tumour shows some clinicopathological differences with respect to the two tumours considered separately, and with respect to von Hippel-Lindau-related cases, although there is no convincing evidence at present to justify considering this association as a separate entity.


Asunto(s)
Cistadenoma Seroso/patología , Neoplasias de las Glándulas Endocrinas/patología , Neoplasias Primarias Múltiples/patología , Neoplasias Pancreáticas/patología , Adulto , Anciano , Cistadenoma Seroso/metabolismo , Neoplasias de las Glándulas Endocrinas/metabolismo , Femenino , Humanos , Persona de Mediana Edad , Proteínas de Neoplasias/metabolismo , Neoplasias Primarias Múltiples/metabolismo , Neoplasias Pancreáticas/metabolismo , Enfermedad de von Hippel-Lindau/metabolismo , Enfermedad de von Hippel-Lindau/patología
11.
Am J Clin Pathol ; 126(4): 593-601, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16938655

RESUMEN

We ascertained the frequency of mitochondrial DNA (mtDNA) D-loop region somatic mutations in pancreatic cancer (PC) and verified whether polymorphisms were linked to diagnosis, prognosis, and PC-associated diabetes mellitus (DM) in 99 PC cases, 42 chronic pancreatitis (CP) cases, 18 pancreatobiliary tract tumors, and 87 healthy control subjects (CSs). Tissue samples were obtained from 19 patients with PC and 5 with CP. The D-loop region was sequenced from all tissue samples and from blood DNA of the same patients and 12 CSs. D-loop somatic mutations were found in 3 PC tissue samples (16%). Four single nucleotide polymorphisms (SNPs; T152C, T16189C, T16519C, A73G), more frequently found in PC than in CS, were analyzed by denaturing high-performance liquid chromatography-restriction fragment length polymorphism using blood DNA as the starting template in all cases. The T allele of 16519 SNP correlated with DM. The survival of patients with PC correlated with tumor stage and grade and with DM at diagnosis. When survival analysis was performed considering only patients with locally advanced disease, the T allele of mtDNA 16519 SNP correlated with shorter life expectancy. mtDNA D-loop somatic mutations, rarely found in PC, cannot be considered causative events for this tumor type and probably are epiphenomena; the mtDNA D-loop 16519 variant, which worsens PC prognosis, seems to be a predisposing genetic factor for DM.


Asunto(s)
Adenocarcinoma/genética , ADN Mitocondrial/genética , Mutación de Línea Germinal , Neoplasias Pancreáticas/genética , Mutación Puntual , Adenocarcinoma/complicaciones , Adenocarcinoma/metabolismo , Adenocarcinoma/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de los Conductos Biliares/complicaciones , Neoplasias de los Conductos Biliares/genética , Neoplasias de los Conductos Biliares/metabolismo , Análisis Mutacional de ADN , Diabetes Mellitus/etiología , Diabetes Mellitus/genética , Diabetes Mellitus/metabolismo , Femenino , Predisposición Genética a la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Pancreáticas/complicaciones , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/mortalidad , Pancreatitis Crónica/complicaciones , Pancreatitis Crónica/genética , Pancreatitis Crónica/metabolismo , Tasa de Supervivencia
12.
Ultrastruct Pathol ; 27(4): 243-52, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12907369

RESUMEN

From November 1995 to May 2002, the authors studied 59 children with suspected primary ciliary dyskinesia (PCD). Samples of ciliated respiratory epithelium were obtained by nasal brushing from 44 patients and by biopsy of bronchial mucosa from 15 patients. Thirty-four/Fifty-nine samples were suitable to obtain a qualitative-quantitative evaluation of ultrastructural ciliary abnormalities. Many ciliary and axoneme alterations were described. This study revealed that quantitative and qualitative ultrastructural assessment of respiratory epithelial cilia plays an important role in the differentiation between primary, secondary, and borderline ciliary abnormalities. Early diagnosis of PCD with appropriate clinical follow-up and treatment is important to prevent irreversible lung tissue damage, namely bronchiectasis.


Asunto(s)
Cilios/ultraestructura , Trastornos de la Motilidad Ciliar/diagnóstico , Microscopía Electrónica , Mucosa Nasal/ultraestructura , Niño , Citodiagnóstico/métodos , Femenino , Humanos , Masculino , Líquido del Lavado Nasal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA